サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：リガーゼ市場- 世界の産業規模、シェア、動向、機会、予測、2017-2027年
市場調査レポート
商品コード
1303140

リガーゼ市場- 世界の産業規模、シェア、動向、機会、予測、2017-2027年

Ligase Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented By Product, By Source, By Application, By End User, By company and By Region
出版日: | 発行: TechSci Research | ページ情報: 英文 116 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.58円

こちらのレポートには、数時間（ご購入金額の10%）分のアナリストへの質問／追加調査サービスが含まれております。

リガーゼ市場- 世界の産業規模、シェア、動向、機会、予測、2017-2027年
出版日: 2023年07月01日
発行: TechSci Research
ページ情報: 英文 116 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 目次
概要

世界のリガーゼ市場は、2023～2027年の予測期間中に目覚ましい成長を遂げると予測されています。

主な要因としては、感染症、遺伝性疾患、慢性疾患の有病率の上昇、研究開発活動の活発化などが挙げられます。リガーゼは、2つの分子を結合させて新しい化学結合を形成する反応を触媒する酵素です。リガーゼは分子診断法において重要な役割を担っており、標的治療薬の安全かつ効果的な応用を確実なものにしています。市場の成長を支えるその他の要因としては、疾病治療に対する需要の増加、研究開発投資の増加、研究開発の開拓、診断薬・製薬企業の拡大、先端技術の採用、世界人口の増加などが挙げられます。また、合併、提携、買収などの戦略的成長の増加が市場の成長を強化しています。例えば、2021年にBLIRT S.A.はテクノロジーパークとグダニスクサイエンスにラボ施設を拡張しました。この新しい研究所では、主要酵素の生産規模の拡大と生産プロセスの改善に取り組んでいます。

疾患治療におけるリガーゼのニーズの高まり

世界中で慢性疾患、感染症、遺伝性疾患が急増していることが、市場の成長を後押ししています。これらの疾患のいずれかに罹患する患者数の増加が一因となっています。そのため、より良い患者ケアを提供するためのより良い治療が必要とされ、市場の成長に拍車をかけています。老人人口だけでなく、若い世代も不健康な選択、ライフスタイルの変化、ファーストフードの消費などにより、これらの病気にかかりやすくなっています。そのため、市場の成長が強化されています。例えば、WHOによると、毎年1,790万人が心血管疾患で死亡し、次いで930万人ががんで死亡、410万人が慢性呼吸器疾患で死亡、最後に腎臓病を含む糖尿病で200万人が死亡しています。同様に、WHOの推計によると、1000人中10人が遺伝性疾患の影響を受けています。

研究開発の増加と多額の投資が市場成長を後押し

リガーゼを治療薬として使用するための研究開発活動が世界中で活発化していることが、市場の成長を後押ししています。研究活動の増加により、リガーゼは変異検出、クローニング、創薬ターゲットなど様々な目的に使用され、市場の成長を後押ししています。例えば、2022年3月、「The Role of SUMO E3 Ligases in Signaling Pathway of Cancer Cells（がん細胞のシグナル伝達経路におけるSUMO E3リガーゼの役割）」と名付けられた調査研究は、細胞の恒常性維持に不可欠な細胞周期制御、タンパク質輸送、DNA損傷修復を含む細胞生理学のいくつかの側面において重要な役割を果たす可逆的翻訳後修飾であると述べています。さらに、酵素ベースの分子診断薬の研究開発活動への投資の増加が市場の成長を促進しています。2021年、メルクはダルムシュタットの世界本社に2億8,250万米ドルを投資しました。同社はヘルスケア事業部門のための新しいトランスレーショナルサイエンスセンターと新しいラーニングセンターの建設に注力しています。

利用可能なカスタマイズ

TechSci Researchは、与えられた市場データをもとに、企業固有のニーズに応じたカスタマイズを提供します。レポートでは以下のカスタマイズが可能です：

企業情報

  • 追加市場参入企業（最大5社）の詳細分析とプロファイリング

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 COVID-19が世界のリガーゼ市場に与える影響

第5章 顧客の声

第6章 世界のリガーゼ市場展望

  • 市場規模と予測
    • 金額別
  • 市場シェアと予測
    • 製品別
    • 供給源別
    • 用途別
    • エンドユーザー別
    • 地域別
    • 企業別
  • 市場マップ

第7章 北米のリガーゼ市場展望

  • 市場規模・予測
    • 金額別
  • 市場シェア・予測
    • 製品別
    • 供給源別
    • 用途別
    • エンドユーザー別
    • 国別
  • 北米：国別分析
    • 米国
    • メキシコ
    • カナダ

第8章 欧州のリガーゼ市場展望

  • 市場規模・予測
    • 金額ベース
  • 市場シェアと予測
    • 製品別
    • 供給源別
    • 用途別
    • エンドユーザー別
    • 国別
  • 欧州国別分析
    • フランス
    • ドイツ
    • 英国
    • イタリア
    • スペイン

第9章 アジア太平洋リガーゼ市場展望

  • 市場規模・予測
    • 金額ベース
  • 市場シェアと予測
    • 製品別
    • 供給源別
    • 用途別
    • エンドユーザー別
    • 国別
  • アジア太平洋：国別分析
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア

第10章 南米のリガーゼ市場展望

  • 市場規模・予測
    • 金額ベース
  • 市場シェアと予測
    • 製品別
    • 供給源別
    • 用途別
    • エンドユーザー別
    • 国別
  • 南米：国別分析
    • ブラジル
    • アルゼンチン
    • コロンビア

第11章 中東・アフリカのリガーゼ市場展望

  • 市場規模・予測
    • 金額ベース
  • 市場シェアと予測
    • 製品別
    • 供給源別
    • 用途別
    • エンドユーザー別
    • 国別
  • MEA：国別分析
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦

第12章 市場力学

  • 促進要因
  • 課題

第13章 市場動向と発展

第14章 競合情勢

  • Bio-Rad Laboratories, Inc.
  • Agilent Technologies, Inc.
  • Codexis, Inc.
  • F. Hoffmann-La Roche AG
  • Merck KGaA
  • Promega Corporation
  • QIAGEN N.V.
  • ArcticZymes Technologies ASA
  • Thermo Fisher Scientific, Inc.
  • Takara Bio Inc.

第15章 戦略的提言

目次
Product Code: 13055

The global ligase market is anticipated to observe impressive growth during the forecast period, 2023-2027. The major factors include the rising prevalence of infectious, genetic, and chronic diseases and the increase in R&D activities are impelling the growth of the market. Ligases are enzymes that catalyze the reaction by joining two molecules to form a new chemical bond. Ligase has a crucial role in the molecular diagnostics method, as it makes sure the safe and effective application of targeted therapeutics. The other factors supporting the market's growth are, increasing demand for disease treatment, increasing investments in R&D, growing research & development, expansion of diagnostics and pharmaceutical companies, adoption of advanced technology, and rising world population. Also, the increasing strategic growth, such as mergers, collaborations, and acquisitions, is strengthening the growth of the market. For instance, in 2021, BLIRT S.A. enlarged its laboratory facility at Technology Park and Gdansk Science. The new laboratory is involved in growing its production scale for key enzymes and improving production processes.

Growing Need for Ligases in Disease Treatment

The surge in incidences of chronic diseases, infectious diseases, and genetic disorders across the globe is bolstering the growth of the market. The rising number of patients suffering from one of these diseases is a contributing factor. Thus, the need for better treatment to provide better patient care is fueling the growth of the market. Not only the geriatric population but the younger generation are prone to these diseases due to unhealthy choices, lifestyle changes, consumption of fast foods, and others. Thus, strengthening the growth of the market. For instance, according to WHO, every year, 17.9 million people die from cardiovascular diseases, followed by 9.3 million deaths by cancer, 4.1 million deaths from chronic respiratory diseases, and lastly, 2.0 million deaths caused by diabetes, including kidney disease. Similarly, according to the estimation of WHO, 10 out of every 1000 people are affected by genetic diseases.

Increasing R&D and Heavy Investments Fuels the Market Growth

The rise in research and development (R&D) activities across the globe to use ligase as a therapeutic intervention is propelling the growth of the market. Owing to the increase in research activities, they are used for various purposes such as mutation detection, cloning, drug targets, and others, thus, in turn, impelling the growth of the market. For instance, in March 2022, a research study named "The Role of SUMO E3 Ligases in Signaling Pathway of Cancer Cells" stated that small ubiquitin-like modifier (SUMO)ylation is a reversible post-translational modification that plays a vital role in several aspects of cell physiology, including cell cycle regulation, protein trafficking, and DNA damage repair, which are essential for cell homeostasis. Moreover, the rising investments in R&D activities for enzyme-based molecular diagnostics are facilitating the growth of the market. In 2021, Merck invested $282.5 million at its global headquarters in Darmstadt. The company is focusing on building a new translational science center for its healthcare business sector and a new learning center.

Market Segmentation

The global ligase market is segmented into product, source, application, end user, and company. Based on product, the market is segmented into quick ligase, T4 DNA ligase, E.Coli DNA ligase, T4 RNA ligase, and others. Based on the source, the market is segmented into Archaebacterium, escherichia coli, Thermus thermophilus, and others. Based on application, the market is segmented into ligase chain reaction, ligase detection reaction, next-generation sequencing, molecular cloning, and others. Based on end-user, the market is divided into biotechnology & pharmaceutical companies, academic & research institutions, and others. In terms of country, the United States is expected to be a lucrative market in the forecast period due to the rising number of research and development and clinical trial programs in the country.

Market Players

Bio-Rad Laboratories, Inc., Agilent Technologies, Inc., Codexis, Inc., F. Hoffmann-La Roche AG, Merck KGaA, Promega Corporation, QIAGEN N.V., ArcticZymes Technologies ASA, Thermo Fisher Scientific, Inc., and Takara Bio Inc. are some of the leading companies operating in the market.

Report Scope

In this report, global ligase market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:

Ligase Market, By Product:

  • Quick Ligase
  • T4 DNA Ligase
  • E.Coli DNA Ligase
  • T4 RNA Ligase
  • Others

Ligase Market, By Source:

  • Archaebacterium
  • Escherichia coli
  • Thermus thermophilus
  • Others

Ligase Market, By application:

  • Ligase Chain Reaction
  • Ligase Detection Reaction
  • Next-Generation Sequencing
  • Molecular Cloning
  • Others

Ligase Market, By End User:

  • Biotechnology & Pharmaceutical Companies
  • Academic & Research Institutions
  • Others

Ligase Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • Europe & CIS
    • Germany
    • France
    • United Kingdom
    • Spain
    • Italy
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Global Ligase Market

Available Customizations

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Executive Summary

4. Impact of COVID-19 on Global Ligase Market

5. Voice of Customer

6. Global Ligase Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product (Quick Ligase, T4 DNA Ligase, E.Coli DNA Ligase, T4 RNA Ligase, Others)
    • 6.2.2. By Source (Archaebacterium, Escherichia coli, Thermus thermophilus, Others)
    • 6.2.3. By Application (Ligase Chain Reaction, Ligase Detection Reaction, Next Generation Sequencing, Molecular Cloning, Others)
    • 6.2.4. By End User (Biotechnology & Pharmaceutical Companies, Academic & Research Institutions, Others)
    • 6.2.5. By Region
    • 6.2.6. By Company (2021)
  • 6.3. Market Map

7. North America Ligase Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By Source
    • 7.2.3. By Application
    • 7.2.4. By End User
    • 7.2.5. By Country
  • 7.3. North America: Country Analysis
    • 7.3.1. United States Ligase Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By Source
        • 7.3.1.2.3. By Application
        • 7.3.1.2.4. By End User
    • 7.3.2. Mexico Ligase Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By Source
        • 7.3.2.2.3. By Application
        • 7.3.2.2.4. By End User
    • 7.3.3. Canada Ligase Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By Source
        • 7.3.3.2.3. By Application
        • 7.3.3.2.4. By End User

8. Europe Ligase Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By Source
    • 8.2.3. By Application
    • 8.2.4. By End User
    • 8.2.5. By Country
  • 8.3. Europe: Country Analysis
    • 8.3.1. France Ligase Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By Source
        • 8.3.1.2.3. By Application
        • 8.3.1.2.4. By End User
    • 8.3.2. Germany Ligase Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By Source
        • 8.3.2.2.3. By Application
        • 8.3.2.2.4. By End User
    • 8.3.3. United Kingdom Ligase Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By Source
        • 8.3.3.2.3. By Application
        • 8.3.3.2.4. By End User
    • 8.3.4. Italy Ligase Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By Source
        • 8.3.4.2.3. By Application
        • 8.3.4.2.4. By End User
    • 8.3.5. Spain Ligase Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By Source
        • 8.3.5.2.3. By Application
        • 8.3.5.2.4. By End User

9. Asia-Pacific Ligase Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By Source
    • 9.2.3. By Application
    • 9.2.4. By End User
    • 9.2.5. By Country
  • 9.3. Asia-Pacific: Country Analysis
    • 9.3.1. China Ligase Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By Source
        • 9.3.1.2.3. By Application
        • 9.3.1.2.4. By End User
    • 9.3.2. India Ligase Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By Source
        • 9.3.2.2.3. By Application
        • 9.3.2.2.4. By End User
    • 9.3.3. Japan Ligase Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By Source
        • 9.3.3.2.3. By Application
        • 9.3.3.2.4. By End User
    • 9.3.4. South Korea Ligase Market Outlook
      • 9.3.4.1. Market Size & Forecast
        • 9.3.4.1.1. By Value
      • 9.3.4.2. Market Share & Forecast
        • 9.3.4.2.1. By Product
        • 9.3.4.2.2. By Source
        • 9.3.4.2.3. By Application
        • 9.3.4.2.4. By End User
    • 9.3.5. Australia Ligase Market Outlook
      • 9.3.5.1. Market Size & Forecast
        • 9.3.5.1.1. By Value
      • 9.3.5.2. Market Share & Forecast
        • 9.3.5.2.1. By Product
        • 9.3.5.2.2. By Source
        • 9.3.5.2.3. By Application
        • 9.3.5.2.4. By End User

10. South America Ligase Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product
    • 10.2.2. By Source
    • 10.2.3. By Application
    • 10.2.4. By End User
    • 10.2.5. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Ligase Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By Source
        • 10.3.1.2.3. By Application
        • 10.3.1.2.4. By End User
    • 10.3.2. Argentina Ligase Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By Source
        • 10.3.2.2.3. By Application
        • 10.3.2.2.4. By End User
    • 10.3.3. Colombia Ligase Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By Source
        • 10.3.3.2.3. By Application
        • 10.3.3.2.4. By End User

11. Middle East and Africa Ligase Market Outlook

  • 11.1. Market Size & Forecast
    • 11.1.1. By Value
  • 11.2. Market Share & Forecast
    • 11.2.1. By Product
    • 11.2.2. By Source
    • 11.2.3. By Application
    • 11.2.4. By End User
    • 11.2.5. By Country
  • 11.3. MEA: Country Analysis
    • 11.3.1. South Africa Ligase Market Outlook
      • 11.3.1.1. Market Size & Forecast
        • 11.3.1.1.1. By Value
      • 11.3.1.2. Market Share & Forecast
        • 11.3.1.2.1. By Product
        • 11.3.1.2.2. By Source
        • 11.3.1.2.3. By Application
        • 11.3.1.2.4. By End User
    • 11.3.2. Saudi Arabia Ligase Market Outlook
      • 11.3.2.1. Market Size & Forecast
        • 11.3.2.1.1. By Value
      • 11.3.2.2. Market Share & Forecast
        • 11.3.2.2.1. By Product
        • 11.3.2.2.2. By Source
        • 11.3.2.2.3. By Application
        • 11.3.2.2.4. By End User
    • 11.3.3. UAE Ligase Market Outlook
      • 11.3.3.1. Market Size & Forecast
        • 11.3.3.1.1. By Value
      • 11.3.3.2. Market Share & Forecast
        • 11.3.3.2.1. By Product
        • 11.3.3.2.2. By Source
        • 11.3.3.2.3. By Application
        • 11.3.3.2.4. By End User

12. Market Dynamics

  • 12.1. Drivers
  • 12.2. Challenges

13. Market Trends & Developments

14. Competitive Landscape

  • 14.1. Bio-Rad Laboratories, Inc.
  • 14.2. Agilent Technologies, Inc.
  • 14.3. Codexis, Inc.
  • 14.4. F. Hoffmann-La Roche AG
  • 14.5. Merck KGaA
  • 14.6. Promega Corporation
  • 14.7. QIAGEN N.V.
  • 14.8. ArcticZymes Technologies ASA
  • 14.9. Thermo Fisher Scientific, Inc.
  • 14.10. Takara Bio Inc.

15. Strategic Recommendations